Anti-programmed cell death ligand 1-based immunotherapy in recurrent hepatocellular carcinoma with inferior vena cava tumor thrombus and metastasis: Three case reports-Reference-Cited by-同舟云学术

Anti-programmed cell death ligand 1-based immunotherapy in recurrent hepatocellular carcinoma with inferior vena cava tumor thrombus and metastasis: Three case reports

Published:2021-07-26 Issue:21 Volume:9 Page:5988-5998
ISSN:2307-8960
Container-title:World Journal of Clinical Cases
language:
Short-container-title:WJCC

Author:

Liu Shao-Ru,Yan Qing,Lin Hao-Ming,Shi Guang-Zi,Cao Yi,Zeng Hong,Liu Chao,Zhang Rui

Publisher

Baishideng Publishing Group Inc.

Subject

General Medicine

Reference25 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Liver resection for hepatocellular carcinoma in 313 Western patients: Tumor biology and underlying liver rather than tumor size drive prognosis

3. Surgical treatment of hepatocellular carcinoma associated with hepatic vein tumor thrombosis

4. Hepatocellular Carcinoma With Intracavitary Cardiac Involvement: A Case Report and Review of the Literature

5. Nomogram for Predicting Long-Term Survival after Synchronous Resection for Hepatocellular Carcinoma and Inferior Vena Cava Tumor Thrombosis: A Multicenter Retrospective Study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy Plus Locoregional Therapy Leading to Curative-Intent Hepatectomy in HCC: Proof of Concept Producing Durable Survival Benefits Detectable with Liquid Biopsy;Cancers;2023-10-30

2. Complete Response to Combined Chemotherapy and Anti-PD-1 Therapy for Recurrent Gallbladder Carcinosarcoma: A Case Report and Literature Review;Frontiers in Oncology;2022-03-14